Corinna Keup

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Metastatic Breast Cancer

Circulating Tumor

Prognostic Factors

Top Venues

Genome medicine

Cellular and molecular life sciences : CMLS

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Corinna Keup, Rainer Kimmig, Sabine Kasimir-Bauer
The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management. Cancers 15 (22) (2023)
Corinna Keup, Rainer Kimmig, Sabine Kasimir-Bauer
Combinatorial Power of cfDNA, CTCs and EVs in Oncology. Diagnostics (Basel, Switzerland) 12 (4) (2022)
Corinna Keup, Vinay Suryaprakash, Markus Storbeck, Oliver Hoffmann, Rainer Kimmig, Sabine Kasimir-Bauer
Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer Patients. Cells 10 (2) (2021)
Corinna Keup, Vinay Suryaprakash, Siegfried Hauch, Markus Storbeck, Peter Hahn, Markus Sprenger-Haussels, Hans-Christian Kolberg, Mitra Tewes, Oliver Hoffmann, Rainer Kimmig, Sabine Kasimir-Bauer
Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer. Genome medicine 13 (1) (2021)
Corinna Keup, Markus Storbeck, Siegfried Hauch, Peter Hahn, Markus Sprenger-Haussels, Oliver Hoffmann, Rainer Kimmig, Sabine Kasimir-Bauer
Multimodal Targeted Deep Sequencing of Circulating Tumor Cells and Matched Cell-Free DNA Provides a More Comprehensive Tool to Identify Therapeutic Targets in Metastatic Breast Cancer Patients. Cancers 12 (5) (2020)
Corinna Keup, Karim Benyaa, Siegfried Hauch, Markus Sprenger-Haussels, Mitra Tewes, Pawel Mach, Ann-Kathrin Bittner, Rainer Kimmig, Peter Hahn, Sabine Kasimir-Bauer
Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients. Cellular and molecular life sciences : CMLS 77 (3) (2019)